Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. It collaborates with innovators from academic institutions, research hospitals and non-profits from small and mid-cap biotechnology companies to global pharmaceutical companies. It funds innovation in the biopharmaceutical industry both directly and indirectly. Directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties. Indirectly when it acquires existing royalties from the original innovators. Its portfolio includes royalties on more than 35 commercial products, including Vertex's Trikafta and Alyftrek, GSK's Trelegy, Roche's Evrysdi, Johnson & Johnson's Tremfya, Biogen's Tysabri and Spinraza, Servier's Voranigo, AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Pfizer's Nurtec ODT, and Gilead's Trodelvy, and over 17 development-stage product candidates.
Find out what a historical investment in Royalty Pharma plc would be worth today using our RPRX stock calculator.
Buying RPRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Royalty Pharma plc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in RPRX
What is the ticker symbol of Royalty Pharma plc?
The ticker symbol for Royalty Pharma plc is RPRX.
How much is one share of RPRX?
One share of RPRX is valued at $68.45 as of 21 November 2026.
What is the market capitalisation of Royalty Pharma plc RPRX?
As of 21 November 2026 Royalty Pharma plc has a market cap of $39.26B.
Does RPRX pay dividends?
Yes, RPRX does pay dividends.
What is the dividend yield for RPRX?
The dividend yield for RPRX is 1.39% as of 21 November 2026.
What is the P/E ratio of RPRX?
The Price to Earnings ratio of RPRX is 44.07.
What is the Earnings Per Share of RPRX?
The Earnings Per Share of RPRX is $1.54.
What is the 52-week high for Royalty Pharma plc stock?
The Royalty Pharma plc 52-week high stock price is $70.37.
What is the 52-week low for Royalty Pharma plc stock?
The Royalty Pharma plc 52-week low stock price is $37.31.
Can I buy RPRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RPRX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RPRX on Stake
Buy RPRX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of RPRX from only US$10 with fractional shares